Medical News

RSS

Leading Chikungunya vaccine in clinical trial phase 2

With the first patient vaccinated, a Phase 2 clinical trial of a promising prophylactic vaccine candidate against Chikungunya fever has now commenced. The product is the most advanced Chikungunya vaccine candidate globally and is developed by the Austrian biotech company Themis Bioscience GmbH.

29 Aug 2016

Dr Google is here to stay - so how do you do it safely?

Almost four out of five Australians (78%) report that they look for information about medicines on the internet, according to a new 2016 survey* released during Be Medicinewise Week (22-28 August).

29 Aug 2016

Blade implants in oral surgery still successful after 50 years

Journal of Oral Implantology – For nearly 50 years, the unique design of the blade implant and the ease of inserting it into a patient’s mouth have made it popular among oral surgeons. As the implant’s golden jubilee approaches, some of its original designers take a new look at a creation that has “passed the test of time.”

29 Aug 2016

Ethicon partners with Touch Surgery to improve global surgical training

Ethicon, Inc., part of the Johnson & Johnson Medical Devices Companies, announces a strategic collaboration with Touch Surgery to help improve patient outcomes by delivering simulated surgical training based on the safe and efficacious use of Ethicon products in a free mobile app that can reach medical professionals in even remote regions of the world.

29 Aug 2016

Janssen seeks to extend DARZALEX license to benefit more multiple myeloma patients

Janssen-Cilag International NV has announced the submission of a Type II variation application to the European Medicines Agency (EMA), seeking to broaden the existing marketing authorisation for the immunotherapy DARZALEX® (daratumumab) to include treatment of adult patients with relapsed multiple myeloma who have received at least one prior therapy. The expanded indication is based on daratumumab in combination with lenalidomide (an immmunomodulatory agent) and dexamethasone, or bortezomib (a PI) and dexamethasone.

29 Aug 2016

Boehringer Ingelheim and Duke expand collaboration to create largest patient registry for idiopathic pulmonary fibrosis (IPF)

Boehringer Ingelheim Pharmaceuticals, Inc. and the Duke Clinical Research Institute (DCRI) announced today the expansion of the Idiopathic Pulmonary Fibrosis – PROspective Outcomes (IPF-PRO) Registry, a patient registry developed to uncover insights into IPF, a rare and serious lung disease. The expansion will increase the study enrollment from 300 patients at 18 study sites to 1,500 patients at approximately 45 sites, creating the largest registry of newly diagnosed IPF patients.

29 Aug 2016

Study results confirm safety and efficacy of INSIGHTEC’s Exablate Neuro system for the treatment of essential tremor

INSIGHTEC, the leader in MR-guided Focused Ultrasound (MRgFUS) therapy, has announced that the New England Journal of Medicine (NEJM) has published the results of a pivotal study of their Exablate Neuro system for the non-invasive treatment of essential tremor (ET). The study met its primary endpoint with patients treated with Exablate Neuro demonstrating a clinically significant 47% improvement in a composite tremor score at three months as compared to no change in the sham cohort.

29 Aug 2016

Research shows AEDs fail to save lives without basic life support education

Automatic external defibrillators (AEDs) fail to save lives when the public does not have basic life support education, according to research presented today at ESC Congress 2016.

29 Aug 2016

NEJM publishes MINDACT trial results

Agendia, Inc., a world leader in personalized medicine and molecular cancer diagnostics, announces the peer-reviewed publication of the primary outcome results of the Microarray In Node-negative and 1 to 3 positive lymph node Disease may Avoid ChemoTherapy (MINDACT) clinical trial in the prestigious New England Journal of Medicine (NEJM). (i, iii, iv) The publication demonstrates that 46% of breast cancer patients considered for chemotherapy, whose tumors are classified MammaPrint Low Risk, have excellent survival without chemotherapy, and can thus be candidates to avoid this toxic therapy.

29 Aug 2016

The rise of disease ecology and its implications for parasitology

The Journal of Parasitology – With a shared focus on host–pathogen relationships, parasitology and disease ecology seem to have a lot in common. But parasitology lacks the eye-catching—and wallet-opening—emphasis on known diseases. By working more closely with disease ecologists, could parasitologists gain more support for work crucial to predicting and controlling infectious diseases?

29 Aug 2016

Study shows non-inferiority of short-term dual antiplatelet therapy in patients with DES placement

A short-term course of dual antiplatelet therapy (DAPT) is non-inferior to a longer course in patients who have undergone placement of a particular kind of drug-eluting stent (DES), researchers reported here.

29 Aug 2016

iPad use before surgery requiring anaesthesia effective in reducing child anxiety

New research presented at this year's World Congress of Anaesthesiologists in Hong Kong (Aug. 28 - Sept. 2) shows that allowing children to use iPads to distract them before surgery requiring general anaesthesia is as effective at lowering their anxiety as conventional sedatives.

29 Aug 2016

Mediterranean Diet linked to mortality risk reduction in patients with cardiovascular disease

The Mediterranean diet is associated with a reduced risk of death in patients with a history of cardiovascular disease, according to results from the observational Moli-sani study presented at ESC Congress 2016 today.

28 Aug 2016

Sudden cardiac death in patients with HCM rarely linked to sport activity

Sudden death in patients with hypertrophic cardiomyopathy (HCM) is rarely associated with exercise, according to research presented at ESC Congress 2016 today by Dr Gherardo Finocchiaro, a cardiologist at St George's University of London, UK.

28 Aug 2016

Risk of motor vehicle accidents increased by 50% in ICD patients

The risk of traffic accidents is increased by 50% in patients with an implantable cardioverter defibrillator (ICD) compared to age and gender matched controls, according to a Danish nationwide registry study presented at ESC Congress 2016 today.

28 Aug 2016

New test may help detect Parkinson's disease in early stages of illness

A test that can detect Parkinson's disease in the early stages of the illness has moved a step closer.

28 Aug 2016

Researchers estimate asthma costs the UK health care £1.1 billion every year

Asthma costs the UK health service at least £1.1 billion each year, researchers have estimated.

28 Aug 2016

Novel activity tracker calculates personalised information about exercise required to reduce CVD risk

A novel activity tracker has been developed that uses heart rate data to personalise the amount of exercise needed to reduce the risk of death from cardiovascular disease. The science behind the tracker is presented for the first time today at ESC Congress 2016.

28 Aug 2016

School intervention costing less than USD $0.20 per student stops increase in BMI

A school intervention costing less than 20 cents per child has stopped unhealthy weight gain. The randomised study is presented at ESC Congress 2016 today by Ms Daniela Schneid Schuh, a nutritionist at the Institute of Cardiology of Rio Grande do Sul in Porto Alegre, Brazil.

28 Aug 2016

Engineered gut bacteria may one day help reduce negative health effects of obesity

A new therapy that involves engineered gut bacteria may one day help reduce the health problems that come with obesity. Incorporating the engineered bacteria into the guts of mice both kept them from gaining weight and protected them against some of the negative health effects of obesity.

28 Aug 2016

Medical News

Leading Chikungunya vaccine in clinical trial phase 2

Dr Google is here to stay - so how do you do it safely?

Blade implants in oral surgery still successful after 50 years

Ethicon partners with Touch Surgery to improve global surgical training

Janssen seeks to extend DARZALEX license to benefit more multiple myeloma patients

Boehringer Ingelheim and Duke expand collaboration to create largest patient registry for idiopathic pulmonary fibrosis (IPF)

Study results confirm safety and efficacy of INSIGHTEC’s Exablate Neuro system for the treatment of essential tremor

Research shows AEDs fail to save lives without basic life support education

NEJM publishes MINDACT trial results

The rise of disease ecology and its implications for parasitology

Study shows non-inferiority of short-term dual antiplatelet therapy in patients with DES placement

iPad use before surgery requiring anaesthesia effective in reducing child anxiety

Mediterranean Diet linked to mortality risk reduction in patients with cardiovascular disease

Sudden cardiac death in patients with HCM rarely linked to sport activity

Risk of motor vehicle accidents increased by 50% in ICD patients

New test may help detect Parkinson's disease in early stages of illness

Researchers estimate asthma costs the UK health care £1.1 billion every year

Novel activity tracker calculates personalised information about exercise required to reduce CVD risk

School intervention costing less than USD $0.20 per student stops increase in BMI

Engineered gut bacteria may one day help reduce negative health effects of obesity

Voltammetry and machine learning for real-time neurotransmitter detection

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

Latest News